Abstract:In the peripheral nervous system, Schwann cells (SCs) play a crucial role in axonal growth, metabolic support of neurons, and the production of myelin sheaths. Expansion of SCs after extraction from human or animal nerves is a long and often low-yielding process. We established a rapid cell culture method using a defined serum-free medium to differentiate human induced pluripotent stem cells (iPSCs) into SCs in only 21 days. The SC identity was characterized by expression of SRY-Box Transcription factor 10 (SOX10), S100b, glial fibrillary acidic protein (GFAP), P75, growth-associated protein 43 (GAP43), and early growth response 2 (EGR2) markers. The SC purity reached 87% as assessed by flow cytometry using the specific SOX10 marker, and 69% based on S100b expression. When SCs were cocultured with iPSC-derived motor neurons two-dimensionally or three-dimensionally (3D), they also expressed the markers of myelin MBP, MPZ, and gliomedin. Likewise, when they were seeded on the opposite side of a porous collagen sponge from motor neurons in the 3D model, they were able to migrate through it and colocalize with motor axons after 8 weeks of maturation. Moreover, they were shown by transmission electron microscopy to form myelin sheaths around motor axons. These results suggest that the use of autologous iPSC-derived SCs for clinical applications such as the repair of peripheral nerve damage, the treatment of spinal cord injuries, or for demyelinating diseases could be a valuable option. Impact Statement Peripheral nerve injuries can cause the complete paralysis of the upper or lower limbs, which considerably reduces the quality of life of patients. To repair this injury, many approaches have been developed by tissue engineering. Combining biomaterials with Schwann cells (SCs) has been shown to be an effective solution for stimulating nerve regeneration. However, the challenge faced concerns the strategy for obtaining autologous SCs to treat patients. A promising approach is to differentiate them from the patient's own cells, previously induced into pluripotent stem cells. We propose a fast culture method to generate functional SCs differentiated from induced pluripotent stem cells.

Differentiation of Human Induced Pluripotent Stem Cells into Mature and Myelinating Schwann Cells

Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells

Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy

Purification and Characterization of Schwann Cells from Adult Human Skin and Nerve

Directed Differentiation of Human Bone Marrow Stromal Cells to Fate-Committed Schwann Cells.

Robust differentiation of human pluripotent stem cells into Schwann cells

Schwann Cell-Like Cells Derived from Human Amniotic Mesenchymal Stem Cells Promote Peripheral Nerve Regeneration Through a MicroRNA-214/c-Jun Pathway

Differentiated Human Adipose-Derived Stromal Cells Exhibit the Phenotypic and Functional Characteristics of Mature Schwann Cells Through a Modified Approach

Direct Conversion of Human Fibroblasts into Schwann Cells that Facilitate Regeneration of Injured Peripheral Nerve In Vivo

IPSC-Derived Sensory Neurons Directing Fate Commitment of Human BMSC-Derived Schwann Cells: Applications in Traumatic Neural Injuries

Development and In Vitro Differentiation of Schwann Cells

Human Schwann-like Cells Derived from Adipose-Derived Mesenchymal Stem Cells Rapidly De-Differentiate in the Absence of Stimulating Medium.

Derivation of Schwann Cell Precursors from Neural Crest Cells Resident in Bone Marrow for Cell Therapy to Improve Peripheral Nerve Regeneration

Challenges in advancing Schwann cell transplantation for spinal cord injury repair

Regenerating the Injured Spinal Cord at the Chronic Phase by Engineered iPSCs-Derived 3D Neuronal Networks

Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells

Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction

Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System

Human neural progenitors derived from integration-free iPSCs for SCI therapy

Glial Differentiation of Human Inferior Turbinate-Derived Stem Cells: a New Source of Cells for Nerve Repair.

Differentiation of Bone Marrow Stem Cells into Schwann Cells for the Promotion of Neurite Outgrowth on Electrospun Fibers.